 

lvy—v-d

WWWM‘WM; No: 3390/3
(SF/2: mW/w €544 ,4,

 

PATIENT HISTORY:

571/1!

CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Endometriai cancer.

LMP DATE: Not applicable.

PROCEDURE: Laparoscopic abdominau hysterectomy. total abdominal hysterectomy, bilateral salpingc-oophorectomy.

I omentectomy. bilateral pelvic and perladnic lymph node dissection, pelvic biopsies.

SPECIFIC CLINICAL QUESTION: Not provided.

OUTSIDE TISSUE DIAGNOSIS: No.
PRIOR MALIGNANCY: No.
CHEMORADIATION THERAPY: No.
OTHER DISEASES: No.

 

ADDENDA:
Addendum

Molecular testing on both endometriai and ovarian tumors identiﬁed loss of heterozygosity (LOH) in both tumors at chromosomes
iq and 14q. The interpretation was: two targets likely of the same clonai origin with moderate reliability. For details. please refer to

molecular pathology report.
CASE SYNOPSIS:

SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL CARCINOMA & CARCINOSARCOMA : HYSTERECTOMY

TUMOR TYPE:

HISTOLOGIC GRADE (epithelial neoplaim}

ARCHITECTURAL GRADE:
NUCLEAR GRADE:
TUMOR SIZE:

PERCENT OF ENDOMETRIAL SURFA

DEPTH OF INVASION:
STRUCTURES INVOLVED:
ANGIOLYMPHATIC INVASION:
PRE-NEOPLASTIC CONDITIONS:
OTHER:

LYMPH MODES POSITIVE:
LYMPH NODES EXAMINED:

T STAGE, PATHOLOGIC:

N STAGE. PATHOLOGIC:

M STAGE, PATHOLOGIC:
FIGO STAGE:

 

SPECIMENS
Endometroid adenocarclnomazNOS

[combined architectural and nuclear]:
Moderately differentiated (FIGO 2))
Moderately differentiated ' "
Grade 2
Maximum dimension: 1 14 mm

CE INVOLVEMENT:

Anterior endcmyometrium: 95 %. Posterior endomyometrlum: 85 %
Less than 1/2 thickness of myometrium
Endocervlcal glands, Cervical stroma

No -

Complex endometriai hyperpiasia with atypia
Adenomyosis

Number of lymph nodes positive: 0

Total number of lymph nodes examined: 6
pT2

pNO

Not applicable

ii

 

SYNOPTIC - PRIMARY QVABIANIUMQRS INCLUDING BORDERLINE TUMORS

TUMOR LOCATION:
PROCEDURE:
TUMOR SIZE:
TUMOR TYPE:
HISTOLOGIC SILVERBERG GRADE:
ARCHITECTURAL PATTERN:
CYTOLOGIC ATYPIA:
MITOTIC COUNTS /10hpf:
VASCULAR INVASION:
TUMOR CAPSULE:
PERITONEAL TUMOR SIZE:
MALIGNANT CELLS IN ASCITES OR
PERITONEAL WASHING:
LYMPH NODES EXAMINED:
LYMPH NODES POSITIVE:

T STAGE, PATHOLOGIC:
N STAGE, PATHOLOGIC:
M STAGE, PATHOLOGIC:
FIGO STAGE:

/
‘\_

Right)
TAH with salpingo-oophorectomy
Maximum dimension (right ovary): 70 mm
Epdgmetroid carcinoma
Moderate y erentiated (6-7 pts)
Papillary (2)
Marked (3)
0—9 (1)
No
Ruptured

UUID:OBC38740-A759-4086-9F03-A139287533CC
TCGA-BG-ABVT-DlA-PR Redacted

l Ilil Iliiill||l|i|li|il||||il||||Illillllliliii||||||||||||
HII llIIlllllliiIlllllilllllllllillllllllllllillilllllll
ll ll lIHIIIIIIIIHIIIIIIIHIIIHIIHIIIIHIHIIlllllllll

l
l
I

Yes

Total number of lymph nodes examined: 6
Number of positive lymph nodes. Right: 0
Number of positive lymph nodes, Left: 0
pT2c

pNO

Not applicable

I to

 
    
 
 

Criteria

Diagnosis Discrepancy -—
Prirr-Iry Tumnr Sile Discrepancy
HIPM Discrepmry

Prim Maiig'mncv History
Dual/Synchronous Primary Na d

an is (:Ircle): 1“”... _

Reviewer inllials Lil

  
     
 
 
 
 

    
  
    
      

